Penile cancer is an aggressive disease and after systemic progression it is virtually incurable. While this squamous cell cancer responds to chemotherapy, successful treatment of lymphatic metastases can only be achieved with aggressive surgical treatment in combination with chemotherapy. However, because penile carcinoma is relatively rare there is a paucity of clinical data on the chemotherapy for this aggressive disease. Recent advances have included the establishment of less toxic regimens incorporating taxanes, while cisplatinum remains central to all regimens. Multi-institutional studies are urgently needed to advance the multimodal care for patients with penile cancer
Squamous cell carcinoma of the penis represents approximately 0.5% of all cancers among men in the U...
Current chemotherapeutic treatment for advanced penile squamous cell carcinoma has substantial side ...
Penile cancer is introduced in chapter 1. Chapter 2 and 3 describe immunohistochemical studies. ...
Penile cancer is rare and receives little public attention. There are few treatment options for adva...
The role of cytotoxic chemotherapy in the management of carcinoma of the penis is not clearly define...
A systematic review of the current treatment options and of the outcomes of penile carcinoma has bee...
In 2021, approximately 122,651 people in the Netherlands were diagnosed with cancer, and one in five...
This review highlights the significant advances made in the diagno-sis and management of penile canc...
A case of penile cancer with bilateral metastatic inguinal lymph nodes in a 68-year-old male is repo...
Penile squamous cell carcinoma (pSCC) is a rare disease, making it difficult to establish a standard...
Squamous penile carcinoma is an uncommon neoplastic disease with an incidence of one in 100 000 men ...
Penile Carcinoma is a malignant disease with low incidence. 0,5 - 1,0 case occurs in population of 1...
Penile carcinoma is a relatively rare disease in the Western world. In this thesis it was shown that...
Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is bas...
While localized penile cancers are typically treated surgically and metastatic penile cancers benefi...
Squamous cell carcinoma of the penis represents approximately 0.5% of all cancers among men in the U...
Current chemotherapeutic treatment for advanced penile squamous cell carcinoma has substantial side ...
Penile cancer is introduced in chapter 1. Chapter 2 and 3 describe immunohistochemical studies. ...
Penile cancer is rare and receives little public attention. There are few treatment options for adva...
The role of cytotoxic chemotherapy in the management of carcinoma of the penis is not clearly define...
A systematic review of the current treatment options and of the outcomes of penile carcinoma has bee...
In 2021, approximately 122,651 people in the Netherlands were diagnosed with cancer, and one in five...
This review highlights the significant advances made in the diagno-sis and management of penile canc...
A case of penile cancer with bilateral metastatic inguinal lymph nodes in a 68-year-old male is repo...
Penile squamous cell carcinoma (pSCC) is a rare disease, making it difficult to establish a standard...
Squamous penile carcinoma is an uncommon neoplastic disease with an incidence of one in 100 000 men ...
Penile Carcinoma is a malignant disease with low incidence. 0,5 - 1,0 case occurs in population of 1...
Penile carcinoma is a relatively rare disease in the Western world. In this thesis it was shown that...
Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is bas...
While localized penile cancers are typically treated surgically and metastatic penile cancers benefi...
Squamous cell carcinoma of the penis represents approximately 0.5% of all cancers among men in the U...
Current chemotherapeutic treatment for advanced penile squamous cell carcinoma has substantial side ...
Penile cancer is introduced in chapter 1. Chapter 2 and 3 describe immunohistochemical studies. ...